C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/54 (2006.01) A61K 38/20 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2147466
This invention provides a class of interleukin-6 (IL-6) muteins which act as IL-6 receptor antagonists, thereby inhibiting the normal function of naturally-occuring IL-6. These IL-6 receptor antagonists are preferably IL-6 molecules containing one or more mutations in the Site II region comprising amino acids 145-163. This invention also provides pharmaceutical compositions comprising IL-6 receptor antagonists with a pharmaceutically acceptable carrier. This invention further provides methods for treating IL-6 related diseases such as sepsis and multiple myeloma, the methods comprising administering to a patient an IL-6 receptor antagonist.
Aarden Lucien A.
Brakenhoff Just P. J.
Borden Ladner Gervais Llp
Central Laboratory Of The Netherlands Red Cross Blood Transfusio
Chiron Corporation
LandOfFree
Interleukin-6 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-6 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-6 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1622646